Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients
Public ClinicalTrials.gov record NCT05174806. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open Label, Controlled, Phase 2, Multi-Center Study to Assess Safety, Tolerability and Efficacy of Adjunctive Treatment With Topically Applied MBN-101 (Pravibismane Topical Suspension) in Subjects With Moderate Diabetic Foot Infection (DFI)
Study identification
- NCT ID
- NCT05174806
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Microbion Corporation
- Industry
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Interventions
- Topical Pravibismane Drug
- Standard of Care Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2022
- Primary completion
- Jan 18, 2024
- Completion
- Jan 18, 2024
- Last update posted
- Nov 3, 2024
2022 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 2
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Limb Preservation Platform, Inc. | Fresno | California | 93710 | — |
| Parkland Comprehensive Wound Center | Dallas | Texas | 75235 | — |
| Parkland Memorial Hospital | Dallas | Texas | 75235 | — |
| University of Texas Southwestern Medical Center University Wound Care Clinic | Dallas | Texas | 75390 | — |
| University of Texas Southwestern Medical Center William P. Clements Jr. University Hospital | Dallas | Texas | 75390 | — |
| Futuro Clinical Trials, LLC | McAllen | Texas | 78501 | — |
| Bio-X-Cell Research | San Antonio | Texas | 78224 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05174806, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 3, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05174806 live on ClinicalTrials.gov.